The board of Quest Diagnostics Incorporated ( NYSE:DGX ) has announced that it will be paying its dividend of $0.80 ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on Quest Diagnostics (DGX – Research Report). The ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

Quest Diagnostics, GE Healthcare and Synchron were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can ...

This was the stock's third consecutive day of gains.

This was the stock's second consecutive day of losses.

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate complex tasks.